Oral Semaglutide Weight-Loss Pill Could Arrive Soon

An FDA decision expected by year's end could introduce an effective, once-daily weight-loss pill as an alternative to injections.

A phase 3 trial showed oral semaglutide at 25 mg significantly reduces body weight, offering patients a highly effective, needle-free option for managing obesity.

Study Details
Novo Nordisk submitted a New Drug Application to the FDA for oral semaglutide based on positive results from the OASIS 4 trial. The drug targets adults with obesity or overweight c…